The nanostructures that externally display TRAIL-mimetic peptides with encapsulated paclitaxel exhibited enhanced in vivo efficacy in a breast cancer model, demonstrating that the two therapies are effective when combined within a single nanostructure specifically targeted to cancer cells [129]. The gene discussed is TNFSF10; the disease is breast carcinoma.